Get informed when a big investor buys or sells
+ FollowOvervalued by 60.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $11.45 Million |
|---|---|
| Enterprise Value | $75.09 Million |
| Annual dividend | $0.07 |
| Dividend yield | 15.00% |
| Earnings per Share | $0 |
| Beta | 0.71 |
| Outstanding Shares | 22,901,692 |
| P/E Ratio | -1.39 |
|---|---|
| PEG | -0.02 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 7.92 |
| Enterprise Value to EBIT | -484.61 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.87 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including th...